Is Ibrutinib-related Atrial Fibrillation Dose Dependent

NCT06224452 · clinicaltrials.gov ↗

UNKNOWN

Status

18000

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancy
Atrial Fibrillation

Interventions

DRUG: ibrutinib exposure

Sponsor

University Hospital, Caen